Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Procalcitonin: Where Are We Now?

Literature DB >> 31733680

Procalcitonin: Where Are We Now?

Abstract

Procalcitonin is a biomarker that is generally elevated in bacterial infections. This review describes a conceptual framework for biomarkers using lessons from the history of troponin, applies this framework to procalcitonin with a review of observational studies and randomized trials in and out of the intensive care unit, and concludes with clinical recommendations and thoughts on how to test a test.

Entities: Chemical Disease Gene Species

Keywords: Antibiotics; Mortality; Procalcitonin; Respiratory tract infection; Sepsis

Mesh：

Substances：

Year: 2019 PMID： 31733680 PMCID： PMC6866676 DOI： 10.1016/j.ccc.2019.08.003

Source DB: PubMed Journal: Crit Care Clin ISSN： 0749-0704 Impact factor: 3.598

92 in total

1. The Swan-Ganz catheters: past, present, and future. A viewpoint.

Authors: Kanu Chatterjee
Journal: Circulation Date: 2009-01-06 Impact factor: 29.690

2. Reflections on the evolution of cardiac biomarkers.

Authors: Jack H Ladenson
Journal: Clin Chem Date: 2011-08-24 Impact factor: 8.327

3. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.

Authors: Andre C Kalil; Mark L Metersky; Michael Klompas; John Muscedere; Daniel A Sweeney; Lucy B Palmer; Lena M Napolitano; Naomi P O'Grady; John G Bartlett; Jordi Carratalà; Ali A El Solh; Santiago Ewig; Paul D Fey; Thomas M File; Marcos I Restrepo; Jason A Roberts; Grant W Waterer; Peggy Cruse; Shandra L Knight; Jan L Brozek
Journal: Clin Infect Dis Date: 2016-07-14 Impact factor: 9.079

4. Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors: Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal: N Engl J Med Date: 2011-06-29 Impact factor: 91.245

5. Monitoring of procalcitonin but not interleukin-6 is useful for the early prediction of anastomotic leakage after colorectal surgery.

Authors: Urszula Zielińska-Borkowska; Naser Dib; Wiesław Tarnowski; Tomasz Skirecki
Journal: Clin Chem Lab Med Date: 2017-06-27 Impact factor: 3.694

6. Clinical value of procalcitonin for patients with suspected bloodstream infection.

Authors: Takuya Hattori; Hideki Nishiyama; Hideki Kato; Shinobu Ikegami; Madoka Nagayama; Saori Asami; Miyuki Usami; Mayuko Suzuki; Itsuka Murakami; Makoto Minoshima; Hiroe Yamagishi; Norihiro Yuasa
Journal: Am J Clin Pathol Date: 2014-01 Impact factor: 2.493

7. Procalcitonin increase after endotoxin injection in normal subjects.

Authors: P Dandona; D Nix; M F Wilson; A Aljada; J Love; M Assicot; C Bohuon
Journal: J Clin Endocrinol Metab Date: 1994-12 Impact factor: 5.958

8. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis.

Authors: E S Nylen; K T Whang; R H Snider; P M Steinwald; J C White; K L Becker
Journal: Crit Care Med Date: 1998-06 Impact factor: 7.598

Review 9. Unrevealing culture-negative severe sepsis.

Authors: Nicolas de Prost; Keyvan Razazi; Christian Brun-Buisson
Journal: Crit Care Date: 2013-09-26 Impact factor: 9.097

10. Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study.

Authors: Philipp Schuetz; Robert Birkhahn; Robert Sherwin; Alan E Jones; Adam Singer; Jeffrey A Kline; Michael S Runyon; Wesley H Self; D Mark Courtney; Richard M Nowak; David F Gaieski; Stefan Ebmeyer; Sascha Johannes; Jan C Wiemer; Andrej Schwabe; Nathan I Shapiro
Journal: Crit Care Med Date: 2017-05 Impact factor: 7.598

22 in total

1. Development of a nomogram to assess the impact of the myocardial injury on the prognosis of COVID-19 patients.

Authors: Mengdi Jin; Zhijun Li; Xinwei Li; Mengtong Xie; Weizhen Li; Lizhe Ai; Yaoyao Sun; Xiaodan Cheng; Yan Sheng; Jinnan Zhang; Nan Jiang; Qiong Yu
Journal: Infez Med Date: 2022-06-01

2. Perspectives on the Immune System in Sepsis.

Authors: Felician Stancioiu; Bogdan Ivanescu; Radu Dumitrescu
Journal: Maedica (Bucur) Date: 2022-06

3. Collective outbreak of severe acute histoplasmosis in immunocompetent Chinese in South America: the clinical characteristics and continuous monitoring of serum cytokines/chemokines.

Authors: Yin-Yin Peng; Shu-Liang Guo; Xiao-Feng Yan; Lv-Lang Zhang; Jing Wang; Guo-Dan Yuan; Gang Qing; Lu-Lu Xu; Qian Zhan
Journal: BMC Prim Care Date: 2022-08-08

4. The Science of Anastomotic Healing.

Authors: Ryan B Morgan; Benjamin D Shogan
Journal: Semin Colon Rectal Surg Date: 2022-03-08

5. Diagnostic Accuracy of Procalcitonin Compared to C-Reactive Protein and Interleukin 6 in Recognizing Gram-Negative Bloodstream Infection: A Meta-Analytic Study.

Authors: Liying Lai; Yijie Lai; Hao Wang; Liang Peng; Ning Zhou; Yi Tian; Yongfang Jiang; Guozhong Gong
Journal: Dis Markers Date: 2020-01-23 Impact factor: 3.434

6. Procalcitonin Correlates With but Is Not Superior to Other Diagnostic Markers of Bacterial Pneumonia.

Authors: Nadia Ayala-Lopez; David R Peaper; Roa Harb
Journal: Am J Clin Pathol Date: 2021-03-15 Impact factor: 2.493

Review 7. Elevated Procalcitonin Is Positively Associated with the Severity of COVID-19: A Meta-Analysis Based on 10 Cohort Studies.

Authors: Yue Shen; Cheng Cheng; Xue Zheng; Yuefei Jin; Guangcai Duan; Mengshi Chen; Shuaiyin Chen
Journal: Medicina (Kaunas) Date: 2021-06-09 Impact factor: 2.430